Consistent with our hypothesis, our findings suggest that high levels of exposure to some phthalate metabolites are associated with lower SHBG levels, obesity, and metabolic syndrome to a greater extent among premenopausal women than among postmenopausal women. The gene discussed is SHBG; the disease is obesity disorder.